Drug interactions in transplant patients: what everyone should know
Authors:
- Erin McCannEMErin McCann
- Sabrina LeeSLSabrina Lee
- Matthew R WeirMWMatthew R Weir
- 1 September 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 18 (5) , 404-411
Abstract
Adverse events due to drug-drug interactions remain a challenge in the postsurgical care of transplant recipients. A combination of potent and selective immunosuppressive drugs, which have a narrow therapeutic index, with medications for the treatment of comorbidities such as dyslipidemia, infection, psychiatric conditions, and hypertension, can lead to life-threatening drug-drug interactions. There are a number of important drug-drug interactions which are important for physicians to consider. It is critical to understand the pharmacodynamics and pharmacokinetics of drug-drug interactions, their potential impact on patient care, and the management strategies. Close therapeutic drug monitoring and evaluation of drug-specific side effects continue to be an important key to minimize adverse events due to drug-drug interactions.Keywords
This publication has 105 references indexed in Scilit:
- Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 StudyClinical Pharmacokinetics, 2007
- The Effect of β-Blocker Use on Cyclosporine Level in Cardiac Transplant RecipientsThe Journal of Heart and Lung Transplantation, 2005
- Interactions Between Cyclosporin and Lipid-Lowering DrugsDrugs, 2003
- Pharmacokinetic Interaction Between Tacrolimus and DiltiazemClinical Pharmacokinetics, 2002
- Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro ModelsThe Journal of Clinical Pharmacology, 2001
- CyclosporinDrugs, 2001
- The Gut as a Barrier to Drug AbsorptionClinical Pharmacokinetics, 2001
- Inhibition and Induction of Cytochrome P450 and the Clinical ImplicationsClinical Pharmacokinetics, 1998
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- Clinically Significant Drug Interactions with CyclosporinClinical Pharmacokinetics, 1996